SIGLEC12 and prostate cancer: Because phenotypic changes in CRC-derived Caco-2 cells generally held true in prostate cancer–derived PC-3 cells, aberrant, functionally defective Siglec-XII expression in other epithelial linings may serve as a shared contributor to and/or predisposition for other inflammation-driven human carcinomas.